SynthesisBMC geriatrics2026
Perioperative neurofilament light chain and glial fibrillary acidic protein as biomarkers of postoperative delirium: a systematic review and meta-analysis.
Synthesis in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathophysiology and biomarkers of delirium in older adults-Narrative review.Zeitschrift fur Gerontologie und Geriatrie · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundPostoperative delirium (POD) is a frequent and serious neurocognitive complication reflecting acute brain dysfunction and predicting long-term cognitive decline. Neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) are biomarkers of neuronal and astroglial injury, but their relevance to POD remains uncertain.
methodsThis systematic review and meta-analysis aimed to determine whether there is an association between perioperative NfL or GFAP levels and POD. PubMed, Embase, and Web of Science were searched until January 2026. Odds ratios (ORs), standardized mean differences (SMDs), and diagnostic performance (AUC) were calculated using random-effects models.
resultsFourteen studies involving 2,604 participants were included, of whom approximately 30% developed POD. In categorical analyses, higher NfL levels were associated with increased POD risk across nine studies (pooled OR = 1.27, 95% CI 1.08-1.50), consistent across plasma (OR = 1.27) and cerebrospinal fluid (CSF) (OR = 1.32) samples. Continuous analyses also showed higher NfL concentrations in delirious patients (Plasma SMD = 0.48; CSF SMD = 0.40). GFAP showed a significant but weaker and less consistent association (overall OR = 1.68, 95% CI 1.15-2.43), mainly driven by plasma data, while continuous analyses were nonsignificant. Diagnostic meta-analysis showed fair discriminative performance for NfL (AUC = 0.68) and moderate accuracy for GFAP (AUC = 0.63).
conclusionsThis meta-analysis demonstrates that perioperative elevations of NfL and GFAP are associated with POD. However, their diagnostic performance remains modest, and current evidence does not support their use as stand-alone diagnostic biomarkers. NfL showed a more stable and reproducible relationship, suggesting its potential role as a marker of perioperative neural stress and as a component of future multimodal delirium risk models.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.